For the next pandemic, dear, do it different. Offer 2B€ in cash for the first company/research group to bring a vaccine to approval, 1B€ for the second and 550M€ for the third. But they MUST transfer all IP/Patents for production to the EU in exchange. 1/2


So the vaccine becomes public knowledge and can be produced at low cost. In a distributed and fast way. In total still cheaper than the current approach where Pfizer and Moderna are free to just not deliver. 2/2

Sign in to participate in the conversation

Mastodon instance for people with Wildeboer as their last name